US2197981051 - Common Stock
QUIDELORTHO CORP
NASDAQ:QDEL (12/26/2024, 8:00:01 PM)
After market: 44.6 0 (0%)44.6
+0.02 (+0.04%)
QuidelOrtho Corp. operates as a vitro diagnostics company. The company is headquartered in San Diego, California and currently employs 7,100 full-time employees. The firm sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The firm provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. The company provides support for its customers across more than 130 countries and territories.
QUIDELORTHO CORP
9975 Summers Ridge Road
San Diego CALIFORNIA 92121
P: 18585521100
CEO: Douglas C. Bryant
Employees: 7100
Website: https://www.quidelortho.com/
Here you can normally see the latest stock twits on QDEL, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: